Advanced search
Publication Cover
Molecular and Cellular Biology Volume 22, 2002 - Issue 4
Submit an article Journal homepage
15
Views
55
CrossRef citations to date
0
Altmetric
Cell Growth and Development

The Neurofibromatosis Type 2 Gene Product, merlin, Reverses the F-Actin Cytoskeletal Defects in Primary Human Schwannoma Cells

Anne-Marie Bashour1 Department of Cell Biology, Neurobiology and Anatomy, University of Cincinnati College of Medicine, Cincinnati, Ohio45267
,
J.-J. Meng1 Department of Cell Biology, Neurobiology and Anatomy, University of Cincinnati College of Medicine, Cincinnati, Ohio45267
,
Wallace Ip1 Department of Cell Biology, Neurobiology and Anatomy, University of Cincinnati College of Medicine, Cincinnati, Ohio45267
,
Mia MacCollin2 Neurology Unit, Massachusetts General Hospital East, Charlestown, Massachusetts02129
&
Nancy Ratner1 Department of Cell Biology, Neurobiology and Anatomy, University of Cincinnati College of Medicine, Cincinnati, Ohio45267Correspondence[email protected]
Pages 1150-1157 | Received 13 Jun 2001, Accepted 02 Nov 2001, Published online: 28 Mar 2023

Citations (55)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Nagathihalli S Nagaraj, Om V Singh & Nipun B Merchant. (2010) Proteomics: a strategy to understand the novel targets in protein misfolding and cancer therapy. Expert Review of Proteomics 7:4, pages 613-623.
Read now
Christopher L Murriel & Steven F Dowdy. (2006) Influence of protein transduction domains on intracellular delivery of macromolecules. Expert Opinion on Drug Delivery 3:6, pages 739-746.
Read now
Guang-Hui Xiao, Ryan Gallagher, Justin Shetler, Kristine Skele, Deborah A. Altomare, Richard G. Pestell, Suresh Jhanwar & Joseph R. Testa. (2005) The NF2 Tumor Suppressor Gene Product, Merlin, Inhibits Cell Proliferation and Cell Cycle Progression by Repressing Cyclin D1 Expression. Molecular and Cellular Biology 25:6, pages 2384-2394.
Read now

Articles from other publishers (52)

Ashish Kumar, Mark Z. Kos, Donna Roybal & Melanie A. Carless. (2023) A pilot investigation of differential hydroxymethylation levels in patient-derived neural stem cells implicates altered cortical development in bipolar disorder. Frontiers in Psychiatry 14.
Crossref
Żaneta Kałuzińska, Damian Kołat, Andrzej K. Bednarek & Elżbieta Płuciennik. (2021) PLEK2, RRM2, GCSH: A Novel WWOX-Dependent Biomarker Triad of Glioblastoma at the Crossroads of Cytoskeleton Reorganization and Metabolism Alterations. Cancers 13:12, pages 2955.
Crossref
Jung-Hyun Cho, Ah-Young Oh, Soyoung Park, So-mi Kang, Min-Ho Yoon, Tae-Gyun Woo, Shin-Deok Hong, Jihwan Hwang, Nam-Chul Ha, Ho-Young Lee & Bum-Joon Park. (2018) Loss of NF2 Induces TGFβ Receptor 1–mediated Noncanonical and Oncogenic TGFβ Signaling: Implication of the Therapeutic Effect of TGFβ Receptor 1 Inhibitor on NF2 Syndrome. Molecular Cancer Therapeutics 17:11, pages 2271-2284.
Crossref
E. Pasmant, C. Louvrier, A. Luscan, J. Cohen, I. Laurendeau, M. Vidaud, D. Vidaud, S. Goutagny, M. Kalamarides & B. Parfait. (2018) Neurofibromatosis type 2 French cohort analysis using a comprehensive NF2 molecular diagnostic strategy. Neurochirurgie 64:5, pages 335-341.
Crossref
A M Petrilli & C Fernández-Valle. (2015) Role of Merlin/NF2 inactivation in tumor biology. Oncogene 35:5, pages 537-548.
Crossref
Maria E.R. Garcia-Rendueles, Julio C. Ricarte-Filho, Brian R. Untch, Iňigo Landa, Jeffrey A. Knauf, Francesca Voza, Vicki E. Smith, Ian Ganly, Barry S. Taylor, Yogindra Persaud, Gisele Oler, Yuqiang Fang, Suresh C. Jhanwar, Agnes Viale, Adriana Heguy, Kety H. Huberman, Filippo Giancotti, Ronald Ghossein & James A. Fagin. (2015) NF2 Loss Promotes Oncogenic RAS-Induced Thyroid Cancers via YAP-Dependent Transactivation of RAS Proteins and Sensitizes Them to MEK Inhibition . Cancer Discovery 5:11, pages 1178-1193.
Crossref
A Petrilli, A Copik, M Posadas, L-S Chang, D B Welling, M Giovannini & C Fernández-Valle. (2013) LIM domain kinases as potential therapeutic targets for neurofibromatosis type 2. Oncogene 33:27, pages 3571-3582.
Crossref
David A. Hilton & Clemens Oliver Hanemann. (2014) Schwannomas and Their Pathogenesis. Brain Pathology 24:3, pages 205-220.
Crossref
Marco Giovannini, Nicolas-Xavier Bonne, Jeremie Vitte, Fabrice Chareyre, Karo Tanaka, Rocky Adams, Laurel M. Fisher, Laurence Valeyrie-Allanore, Pierre Wolkenstein, Stephane Goutagny & Michel Kalamarides. (2014) mTORC1 inhibition delays growth of neurofibromatosis type 2 schwannoma. Neuro-Oncology 16:4, pages 493-504.
Crossref
P K Manchanda, G N Jones, A A Lee, D R Pringle, M Zhang, L Yu, K M D La Perle & L S Kirschner. (2012) Rac1 is required for Prkar1a-mediated Nf2 suppression in Schwann cell tumors. Oncogene 32:30, pages 3491-3499.
Crossref
Elisabeth Castellanos, Imma Rosas, Ares Solanes, Isabel Bielsa, Conxi Lázaro, Cristina Carrato, Cristina Hostalot, Pepe Prades, Francesc Roca-Ribas, Ignacio Blanco & Eduard Serra. (2012) In vitro antisense therapeutics for a deep intronic mutation causing Neurofibromatosis type 2. European Journal of Human Genetics 21:7, pages 769-773.
Crossref
Minja Laulajainen, Maria Melikova, Taru Muranen, Olli Carpén & Mikaela Grönholm. (2012) Distinct overlapping sequences at the carboxy-terminus of merlin regulate its tumour suppressor and morphogenic activity. Journal of Cellular and Molecular Medicine 16:9, pages 2161-2175.
Crossref
Wei Li, Jonathan Cooper, Matthias A Karajannis & Filippo G Giancotti. (2012) Merlin: a tumour suppressor with functions at the cell cortex and in the nucleus. EMBO reports 13:3, pages 204-215.
Crossref
Steven L. Carroll. (2011) Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms. Acta Neuropathologica 123:3, pages 321-348.
Crossref
Wei Li, Jonathan Cooper, Matthias A. Karajannis & Filippo G. Giancotti. (2012) Merlin: a tumour suppressor with functions at the cell cortex and in the nucleus. EMBO reports.
Crossref
Andrew H. Kaye, Robert J.S. Briggs & Andrew P. Morokoff. 2012. Brain Tumors. Brain Tumors 518 569 .
Hoi Yee Chow, Dina Stepanova, Jennifer Koch & Jonathan Chernoff. (2010) p21-Activated Kinases Are Required for Transformation in a Cell-Based Model of Neurofibromatosis Type 2. PLoS ONE 5:11, pages e13791.
Crossref
V.P. Collins. 2010. Meningiomas. Meningiomas 127 134 .
Michael S. Hildebrand, Murad Husein & Richard J.H. Smith. 2010. Cummings Otolaryngology - Head and Neck Surgery. Cummings Otolaryngology - Head and Neck Surgery 2086 2099 .
Dominique Lallemand, Aurelie Lampin Saint-Amaux & Marco Giovannini. (2009) Tumor-suppression functions of merlin are independent of its role as an organizer of the actin cytoskeleton in Schwann cells. Journal of Cell Science 122:22, pages 4141-4149.
Crossref
Nune Darbinian, Yuri Popov, Kamel Khalili & Shohreh Amini. (2008) Creation of a bi-directional protein transduction system for suppression of HIV-1 expression by p27SJ. Antiviral Research 79:2, pages 136-141.
Crossref
Marianne F. James, Johanna M. Lelke, Mia MacCollin, Scott R. Plotkin, Anat O. Stemmer-Rachamimov, Vijaya Ramesh & James F. Gusella. (2008) Modeling NF2 with human arachnoidal and meningioma cell culture systems: NF2 silencing reflects the benign character of tumor growth. Neurobiology of Disease 29:2, pages 278-292.
Crossref
Jingrong Lü, Jing Zou, Hao Wu & Lihui Cai. (2008) Compensative Shuttling of Merlin to Phosphorylation on Serine 518 in Vestibular Schwannoma. The Laryngoscope 118:1, pages 169-174.
Crossref
M Curto & A I McClatchey. (2007) Nf2/Merlin: a coordinator of receptor signalling and intercellular contact. British Journal of Cancer 98:2, pages 256-262.
Crossref
Pierig Lepont, John T. Stickney, Lauren A. Foster, Jin-Jun Meng, Robert F. Hennigan & Wallace Ip. (2008) Point mutation in the NF2 gene of HEI-193 human schwannoma cells results in the expression of a merlin isoform with attenuated growth suppressive activity. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 637:1-2, pages 142-151.
Crossref
Daniel R. Scoles. (2008) The merlin interacting proteins reveal multiple targets for NF2 therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1785:1, pages 32-54.
Crossref
. 2008. The Genetics and Molecular Biology of Neural Tumors. The Genetics and Molecular Biology of Neural Tumors 1 41 .
Jonathan Riley, Alejandro Spiotta & Nicholas Boulis. (2007) Experimental therapeutic approaches to peripheral nerve tumors. Neurosurgical Focus 22:6, pages 1-17.
Crossref
Courtney Thaxton, Jorge Lopera, Marga Bott, M. Elizabeth Baldwin, Poonam Kalidas & Cristina Fernandez-Valle. (2007) Phosphorylation of the NF2 tumor suppressor in Schwann cells is mediated by Cdc42-Pak and requires paxillin binding. Molecular and Cellular Neuroscience 34:2, pages 231-242.
Crossref
A. Melnick. 2007. Acute Promyelocytic Leukemia. Acute Promyelocytic Leukemia 221 243 .
Yoko Nakai, Yi Zheng, Mia MacCollin & Nancy Ratner. (2006) Temporal Control of Rac in Schwann Cell–Axon Interaction Is Disrupted in NF2 -Mutant Schwannoma Cells . The Journal of Neuroscience 26:13, pages 3390-3395.
Crossref
Nitasha Manchanda, Anna Lyubimova, Hsin-Yi Henry Ho, Marianne F. James, James F. Gusella, Narayanaswamy Ramesh, Scott B. Snapper & Vijaya Ramesh. (2005) The NF2 Tumor Suppressor Merlin and the ERM Proteins Interact with N-WASP and Regulate Its Actin Polymerization Function. Journal of Biological Chemistry 280:13, pages 12517-12522.
Crossref
Andreas Hasse, André Rosentreter, Ziqiang Spoerl, Maria Stumpf, Angelika A. Noegel & Christoph S. Clemen. (2005) Coronin 3 and its role in murine brain morphogenesis. European Journal of Neuroscience 21:5, pages 1155-1168.
Crossref
Thomas N. Tully. (2005) Diagnostic challenge. Seminars in Avian and Exotic Pet Medicine 14:1, pages 65-70.
Crossref
Thorsten Wiederhold, Ming-Fen Lee, Marianne James, Ralph Neujahr, Nicole Smith, Anita Murthy, John Hartwig, James F Gusella & Vijaya Ramesh. (2004) Magicin, a novel cytoskeletal protein associates with the NF2 tumor suppressor merlin and Grb2. Oncogene 23:54, pages 8815-8825.
Crossref
Klaus P Hoeflich & Mitsuhiko Ikura. (2004) Radixin: cytoskeletal adopter and signaling protein. The International Journal of Biochemistry & Cell Biology 36:11, pages 2131-2136.
Crossref
Nirmal P. Patel, Anand N. Mhatre & Anil K. Lalwani. (2004) Molecular Pathogenesis of Skull Base Tumors. Otology & Neurotology 25:4, pages 636-643.
Crossref
Vijaya Ramesh. (2004) Merlin and the ERM proteins in Schwann cells, neurons and growth cones. Nature Reviews Neuroscience 5:6, pages 462-470.
Crossref
John T. Stickney, W. Clark Bacon, Meghan Rojas, Nancy Ratner & Wallace Ip. (2004) Activation of the Tumor Suppressor Merlin Modulates Its Interaction with Lipid Rafts. Cancer Research 64:8, pages 2717-2724.
Crossref
Kaija Alfthan, Leena Heiska, Mikaela Grönholm, G. Herma Renkema & Olli Carpén. (2004) Cyclic AMP-dependent Protein Kinase Phosphorylates Merlin at Serine 518 Independently of p21-activated Kinase and Promotes Merlin-Ezrin Heterodimerization. Journal of Biological Chemistry 279:18, pages 18559-18566.
Crossref
Brigitte C. Widemann. (2004) Merlin PAKs a Punch. The Cancer Journal 10:1, pages 8-11.
Crossref
Guang-Hui Xiao, Jonathan Chernoff & Joseph R. Testa. (2003) NF2: The wizardry of merlin. Genes, Chromosomes and Cancer 38:4, pages 389-399.
Crossref
Lynne A. Fieber. (2003) Voltage-Gated ion currents of schwann cells in cell culture models of human neurofibromatosis. Journal of Experimental Zoology 300A:1, pages 76-83.
Crossref
Tamara Utermark, Katherine Kaempchen & C. Oliver Hanemann. (2006) Pathological Adhesion of Primary Human Schwannoma Cells is Dependent on Altered Expression of Integrins. Brain Pathology 13:3, pages 352-363.
Crossref
Siobhan M Cashman, David J Morris & Rajendra Kumar-Singh. (2003) Evidence of protein transduction but not intercellular transport by proteins fused to HIV tat in retinal cell culture and in vivo. Molecular Therapy 8:1, pages 130-142.
Crossref
Olivier D. Lohez, Caroline Reynaud, Franck Borel, Paul R. Andreassen & Robert L. Margolis. (2003) Arrest of mammalian fibroblasts in G1 in response to actin inhibition is dependent on retinoblastoma pocket proteins but not on p53. Journal of Cell Biology 161:1, pages 67-77.
Crossref
Michelle Becker‐Hapak & Steven F. Dowdy. (2003) Protein Transduction: Generation of Full‐Length Transducible Proteins Using the TAT System . Current Protocols in Cell Biology 18:1.
Crossref
Michael E. Baser, D. Gareth R. Evans & David H. Gutmann. (2003) Neurofibromatosis 2. Current Opinion in Neurology 16:1, pages 27-33.
Crossref
Rosalie E. Ferner & Michael J. OʼDoherty. (2002) Neurofibroma and schwannoma. Current Opinion in Neurology 15:6, pages 679-684.
Crossref
D. R. Scoles, V. D. Nguyen, Y. Qin, C.-X. Sun, H. Morrison, D. H. Gutmann & S.-M. Pulst. (2002) Neurofibromatosis 2 (NF2) tumor suppressor schwannomin and its interacting protein HRS regulate STAT signaling. Human Molecular Genetics 11:25, pages 3179-3189.
Crossref
Chun-Xiao Sun, Victoria A. Robb & David H. Gutmann. (2002) Protein 4.1 tumor suppressors: getting a FERM grip on growth regulation. Journal of Cell Science 115:21, pages 3991-4000.
Crossref
David H. Gutmann & Marco Giovannini. (2002) Mouse Models of Neurofibromatosis 1 and 2. Neoplasia 4:4, pages 279-290.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.